UK cost agency backs Pradaxa for stroke prevention
by on Nov.01, 2011, under Health and Fitness
Britain's healthcare cost-effectiveness watchdog NICE has recommended the use of Boehringer Ingelheim's new anti-clotting pill Pradaxa, after getting additional information on the medicine from the company.
View full post on Yahoo! Health News
